Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3739686017 | Dinoprostone only product in vaginal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3739687014 | Product containing only dinoprostone in vaginal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dinoprostone only product in vaginal dose form | Has active ingredient | Dinoprostone (substance) | true | Inferred relationship | Some | 1 | |
| Dinoprostone only product in vaginal dose form | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Dinoprostone only product in vaginal dose form | Has manufactured dose form | Vaginal dose form (dose form) | true | Inferred relationship | Some | ||
| Dinoprostone only product in vaginal dose form | Is a | Dinoprostone-containing product in vaginal dose form | true | Inferred relationship | Some | ||
| Dinoprostone only product in vaginal dose form | Is a | Dinoprostone only product | true | Inferred relationship | Some | ||
| Dinoprostone only product in vaginal dose form | Plays role | Oxytocic therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dinoprostone 400 microgram/mL vaginal gel | Is a | True | Dinoprostone only product in vaginal dose form | Inferred relationship | Some | |
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Is a | True | Dinoprostone only product in vaginal dose form | Inferred relationship | Some | |
| Dinoprostone 3 mg vaginal tablet | Is a | True | Dinoprostone only product in vaginal dose form | Inferred relationship | Some | |
| Dinoprostone 10 mg prolonged-release vaginal pessary | Is a | True | Dinoprostone only product in vaginal dose form | Inferred relationship | Some | |
| Dinoprostone 10 mg prolonged-release vaginal delivery system | Is a | True | Dinoprostone only product in vaginal dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR